Skip to main content

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Agency: Centers for Disease Control and Prevention - ERA

Assistance Listings
  • 93.061 -- Innovations in Applied Public Health Research

Forecasted opportunityLast Updated: Nov 4, 2026

Important dates

  • Forecasted post date: December 1, 2026
  • Forecasted application due date: February 1, 2027
  • Forecasted award date: August 29, 2027
  • Forecasted project start date: September 30, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $4,500,000
  • Expected awards: 3

Award min.

$0

Award max.

$500,000

  • Funding opportunity number:RFA-TS-27-018
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: July 8, 2026
  • Archive date: Not specified
  • Version: 3

View version history on Grants.gov

Summary

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.  

Eligibility

Government

  • County governments
  • Federally recognized Native American tribal governments
  • City or township governments
  • State governments
  • Special district governments
  • Public and Indian housing authorities

Education

  • Independent school districts
  • Public and state institutions of higher education
  • Private institutions of higher education

Miscellaneous

  • Unrestricted
  • Other

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Additional information on eligibility

Additional Eligibility Information to be included in the NOFO.

Documents

No documents are currently available.

Agency contact information

Email: ncipc_erpo@cdc.gov

ncipc_erpo@cdc.gov

Dr. Candis Hunter 770-488-1347

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov